Bumper Offer - Urjas oil Just @ Rs. 1
Decakem C is a prescription drug, available for use as Drops. Decakem C also has some secondary and off-label uses. These are listed below.
The right dosage of Decakem C depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Decakem C also has some side effects, the most common being Eye Burning, Eye irritation. Usually, these side effects of Decakem C go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Decakem C's effect is Unknown during pregnancy and Unknown for lactating mothers. It is important to know if Decakem C has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Decakem C related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Liver Disease, Infections must refrain from the use of Decakem C since this can cause severe adverse effects. Some other conditions that can be affected by Decakem C are listed in the contraindications section below.
Drug reaction of Decakem C with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Decakem C is considered not safe while driving, and is not addictive.
Decakem C is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Decakem C is used -
Common
Is the use of Decakem C safe for pregnant women?
No research has not been done till date on the safety of Decakem C for pregnant women. So its effects on pregnant women are unknown.
Is the use of Decakem C safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Decakem C for breastfeeding women are not known.
What is the effect of Decakem C on the Kidneys?
No research work has been carried out till date on effects of Decakem C on kidney. So it is not known whether taking Decakem C will cause side effects on kidney or not.
What is the effect of Decakem C on the Liver?
Information about safety of Decakem C for the liver is not available since scientific research on this is yet to be done.
What is the effect of Decakem C on the Heart?
In the absence of any scientific study on the side effects of Decakem C on the heart, information on safety of Decakem C for the heart is unavailable.
Decakem C should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Decakem C unless your doctor advises you to do so -
Is this Decakem C habit forming or addictive?
Decakem C does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Decakem C, you should not drive or work on any heavy machine, as Decakem C can make you drowsy.
Is it safe?
Decakem C should be used only after doctor's advice.
Is it able to treat mental disorders?
Decakem C is unable to treat or cure mental disorders.
Interaction between Food and Decakem C
There is no information on the effects of taking Decakem C with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Decakem C
It is difficult to say anything about the effect of Decakem C and alcohol. No research has been done on this yet.
Yes, Decakem C can be taken with ranitidine. No harmful drug interaction has been reported between them. It is safe to take Decakem C along with ranitidine if taken as directed by a doctor. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
Discontinuing Decakem C on your own can increase the chances of bacterial resistance and infection relapse. It is recommended that you always consult your doctor if you have decided to discontinue this medicine.
Yes, Decakem C may cause gray baby syndorme in newborn infants especially in premature baby, if this drug is given in higher doses. Gray baby syndrome is a rare side effect that occurs due to accumulation of the chloramphenicol in the newborn infant. The cause of gray baby syndrome is that the newborn baby lacks the some liver enzymes which are necessary to metabolize and removes this drug from the body. The accumulation of the chloramphenicol in the body leads to toxicity which causes development of symptoms such as vomiting, gray color of the skin, blue discoloration of lips and skin. To avoid gray baby syndrome the doses of Decakem C must be lowered and adjusted as per the need.
Yes, Decakem C might cause aplastic anemia which is a type of anemia in which the body is not able to make new red blood cells. Decakem C induces aplastic anemia by suppressing the red bone marrow which produces new red blood cells. However, it is reversible and the red blood cells production by red bone marrow is restored after discontinuation of this drug.
Decakem C is bacteriostatic at the therapeutic dose that means it inhibits the growth of the bacteria but it can be bactericidal at higher doses. It works by inhibiting the protein synthesis in bacteria which it needs to survive. In the absence of protein synthesis, the bacterial growth is stunned and slowed.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Chloromycetin sodium succinate (chaloramphenicol sodium succinate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 739-742
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Decadron® (dexamethasone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hemady™ (dexamethasone)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hexadrol® (dexamethasone sodium phosphate)
National Institutes of Health U.S. National Library of Medicine [Internet]: Dexamethasone Ophthalmic. American Society of Health-System Pharmacists
Package Leaflet Information For The User [Internet]: Chloramphenicol 1% w/w Eye Ointment. Martindale Pharmaceuticals Ltd
leaflet [Internet]: Minims® Dexamethasone Sodium Phosphate 0.1% w/v. Minims